A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma
Tekijät: Routila Johannes, Suvila Karri, Grénman Reidar, Leivo Ilmo, Westermarck Jukka, Ventelä Sami
Kustantaja: biomed central
Julkaisuvuosi: 2021
Journal: BMC Cancer
Lehden akronyymi: BMC Cancer
Artikkelin numero: 868
Vuosikerta: 21
eISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08618-6
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/66362529
Background: Currently, no clinically useful biomarkers for radioresistance are available in head and neck squamous cell carcinoma (HNSCC). This study assesses the usefulness of Cell Line Microarray (CMA) method to enhance immunohistochemical screening of potential immunohistochemical biomarkers for radioresistance in HNSCC cell lines.
Methods: Twenty-nine HNSCC cell lines were cultured, cell pellets formalin-fixed, paraffin-embedded, and arrayed. Radioresistance features of the cell lines were combined to immunohistochemical stains for p53, NDFIP1, EGFR, stem cell marker Oct4, and PP2A inhibitor CIP2A.
Results: Expression of p53, EGFR or CIP2A did not indicate intrinsic radioresistance in vitro. Stem cell marker Oct4 nuclear positivity and NDFIP1 nuclear positivity was correlated with increased intrinsic radioresistance.
Conclusion: The usefulness of CMA in analysis of HNSCC cell lines and discovery of biomarkers is demonstrated. CMA is very well adapted to both testing of antibodies in a large panel of cell lines as well as correlating staining results with other cell line characteristics. In addition, CMA-based antibody screening proved an efficient and relatively simple method to identify potential radioresistance biomarkers in HNSCC.
Ladattava julkaisu This is an electronic reprint of the original article. |